A股異動 | 四川美豐(000731.SZ)漲超6% 產品價格上漲
格隆匯5月6日丨四川美豐(000731.SZ)股價繼續走強,盤中最高5.57元創8個月新高,現報5.5元,漲幅6.38%,最新總市值32.5億,近4個交易日累計漲超14%。公司主營化學肥料、三聚氰胺等業務。卓創資訊此前發佈消息稱,春節之後中國三聚氰胺市場走出了“六親不認”的步伐,一路高歌,新單出廠價格已經飆漲至14000元/噸(湖北華強),去年同期為4500元/噸左右,漲幅高達211%。目前價格已經完全超越了2016年的高位,創出近十年來的新高,並且仍未有停止的跡象。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.